Okami Medical

Advanced Technology for Peripheral Vascular Occlusion.

[Okami Medical @OkamiMedical]

LOBO® is the first & only peripheral embolization device designed for complete occlusion—without sacrificing deliverability or stability, even in complex cases.

Reduces blood flow, accelerates hemostasis, enables precise, rapid thrombosis.

LEARN MORE. https://t.co/uVV4A67mP9

[Okami Medical @OkamiMedical]

Stability isn’t optional.

LOBO is engineered to stay exactly where it’s placed—even in curved, challenging anatomy. Its multi-segment HDBRAID® design delivers vessel conformity, radial stiffness, and confident deployment.

LEARN MORE. https://t.co/uVV4A66OZB

[Okami Medical @OkamiMedical]

We’re bringing LOBO HDBRAID to GEST 2026 in NY—see it in action. The first & only peripheral embolization device purpose-built for fast & complete occlusion. LOBO enables single-device occlusions in a wide variety of cases.

📍 Visit Booth 114
🎓 Attend our sessions May 14 & 15

[Okami Medical @OkamiMedical]

Rapid occlusion and a single device implanted per vessel.

Dr. Mohammed Loya recently achieved these results with LOBO for a renal AVM embolization.

#OkamiMedical #LOBO #Embolization #InterventionalRadiology #MedTech

[Okami Medical @OkamiMedical]

We’re headed to GEST 2026 in NY—see what’s next in peripheral embolization. Discover the LOBO HDBRAID Vascular Occluder, a 1st & only device designed for complete occlusion with deliverability & stability physicians need to navigate even the most complex cases with confidence.

[Okami Medical @OkamiMedical]

LOBO device was used in a 28-year-old patient, 27 weeks pregnant, presenting with bilateral pulmonary aneurysms—requiring urgent, precise intervention to protect mother & child. With continuous fetal monitoring by obstetrics team, physicians successfully treated both aneurysms.

[Okami Medical @OkamiMedical]

The UNC pulmonary arteriovenous malformations (PAVM) experience is now published. This single-center data set shows how the uniquely engineered LOBO device delivers promising results in this critical patient population.

READ https://t.co/JRmDbKFD7a

LOBO https://t.co/3zsx7qGY6n

[Okami Medical @OkamiMedical]

"One of my favorite properties of LOBO is that there's essentially no streak artifact….Having something that doesn't impact the surrounding tissue in terms of visibility has been excellent."

Just one way the LOBO system is reshaping embolization.

Listen to Backtable for more.

[Okami Medical @OkamiMedical]

We’re proud to announce the first patient enrolled in the ALPHA Registry, advancing real-world evaluation of the LOBO® Vascular Occluder. A key step in strengthening evidence for innovative embolization solutions.

Read more: https://t.co/qXn4dJmZ1C

[Okami Medical @OkamiMedical]

The LOBO® Vascular Occluder is the first and only peripheral embolization device designed to provide complete occlusion with the deliverability and stability physicians need to navigate with confidence, even during the most complex embolization procedures.

Discover LOBO at SIR.

[Okami Medical @OkamiMedical]

Heading to SIR next week? Don't miss the LOBO lunch symposium! Join us for a case-based discussion on the LOBO device and discover how it's impacting embolization practice nationwide - through three unique perspectives.

April 11, 12:10-1:10 pm, Room 801B

https://t.co/4TAT14SJjJ

[Okami Medical @OkamiMedical]

LOBO®with HDBRAID® was designed to eliminate the need for multiple devices per vessel, resulting in higher efficiency and lower costs.

Learn More: https://t.co/fQ5q0hfCbQ

[Okami Medical @OkamiMedical]

We’re heading to SIR in Toronto and bringing the future of vascular occlusion with us. Learn about the LOBO® HDBRAID® Vascular Occluder.

Attend: LOBO & GO: CASE-BASED LEARNINGS ON NEXT-GEN EMBOLIZATION, April 11, 12:10 – 1:10 pm, Room 801B. Register here: https://t.co/4TAT14SJjJ

[Okami Medical @OkamiMedical]

Built on decades of experience, our engineers created a new class of nitinol braiding—HDBRAID. Ultra-thin wires woven at high density form a breakthrough micro pore mesh for optimal occlusion, stability, and flexible delivery. LEARN MORE. https://t.co/uVV4A66OZB

[Okami Medical @OkamiMedical]

Register for our lunch symposium at SIR 2026. Join us for case-based learning with a panel of 3 experienced implanters highlighting the HDBRAID® difference in a wide range of cases.

Saturday, April 11 from 12:10-1:10 pm, Room 801B

Register: https://t.co/4TAT14SJjJ

#SIR26TOR

[Okami Medical @OkamiMedical]

A single LOBO9 device was deployed via a 6 Fr Ansel sheath to achieve occlusion of a collateral vessel measuring 7.7 mm in diameter. Successful embolization confirmed with angiography, with 5-minute occlusion time. Case from Dr. Gurvan Blackman. More Cases https://t.co/WGo0LVRczP

[Okami Medical @OkamiMedical]

Okami Medical announces $45 million financing and new CEO appointment to drive next phase of growth. LEARN MORE https://t.co/wtVDl70tth

#OkamiMedical #HDBRAID #LoboOccluder

[Okami Medical @OkamiMedical]

We’re excited to announce that Drew Hykes has been appointed President & CEO of Okami Medical, effective Oct 6.

Drew brings 20+ years of medtech leadership, most recently serving as CEO of Inari Medical.

Welcome to the team, Drew!

#Leadership #OkamiMedical

[Okami Medical @OkamiMedical]

LOBO enables rapid, single-device vessel occlusion that may reduce procedure duration, fluoroscopy time, and total implant costs. Does this resonate?

Get the full analysis and decide for yourself. https://t.co/dFwMSRe1ZX

[Okami Medical @OkamiMedical]

Why? Its unique design and deliverability make it a compelling alternative to traditional coil-based approaches. And it could save your practice hundreds (or thousands) per case. LOBO is changing how physicians think about embolization.

Learn more https://t.co/dFwMSRe1ZX